186 related articles for article (PubMed ID: 33279839)
1. IGF2BP3 Expression Correlates With Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Wakita A; Motoyama S; Sato Y; Nagaki Y; Fujita H; Terata K; Imai K; Maeda E; Minamiya Y
J Surg Res; 2021 Mar; 259():137-144. PubMed ID: 33279839
[TBL] [Abstract][Full Text] [Related]
2. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
BMC Cancer; 2021 Nov; 21(1):1192. PubMed ID: 34753448
[TBL] [Abstract][Full Text] [Related]
3. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma.
Chen YH; Lu HI; Lo CM; Hsiao CC; Li SH
Surgery; 2020 Mar; 167(3):620-627. PubMed ID: 31889545
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes.
Chen P; Zhao X; Zhou F; Song X; Hu S; Jin Y; Wang X; Han X; Fan Z; Wang R; Li B; Han W; Wang P; Li J; Wan L; Zhang L; Bao Q; Chang F; Qin Y; Chang Z; Ku J; Yang H; Yuan L; Ren J; Li X; Wang L
Cancer Biol Med; 2020 Feb; 17(1):219-226. PubMed ID: 32296589
[No Abstract] [Full Text] [Related]
5. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.
Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A
Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677
[No Abstract] [Full Text] [Related]
6. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
[TBL] [Abstract][Full Text] [Related]
7. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.
Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C
Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy.
Wakita A; Motoyama S; Nanjo H; Sato Y; Yoshino K; Sasaki T; Kawakita Y; Liu J; Imai K; Saito H; Minamiya Y
Anticancer Res; 2017 Mar; 37(3):1433-1441. PubMed ID: 28314315
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
[TBL] [Abstract][Full Text] [Related]
10. High TLR4 expression predicts a poor prognosis after esophagectomy for advanced thoracic esophageal squamous cell carcinoma.
Sato Y; Motoyama S; Wakita A; Kawakita Y; Liu J; Nagaki Y; Nanjo H; Ito S; Terata K; Imai K; Minamiya Y
Esophagus; 2020 Oct; 17(4):408-416. PubMed ID: 32170544
[TBL] [Abstract][Full Text] [Related]
11. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Pretreatment PET/CT Nodal Status on Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiation.
Chen JX; Lu TY; Fang HY; Lin YS; Lee JM
World J Surg; 2020 Jul; 44(7):2323-2331. PubMed ID: 32296872
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral
Yamamura K; Izumi D; Kandimalla R; Sonohara F; Baba Y; Yoshida N; Kodera Y; Baba H; Goel A
Clin Cancer Res; 2019 Oct; 25(20):6170-6179. PubMed ID: 31358543
[TBL] [Abstract][Full Text] [Related]
14. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
15. High expression of guanine nucleotide-binding protein-like-3-like is associated with poor prognosis in esophageal cancer.
Dai G; Guo Z; Chen H; Jiang M; Zhou H; Bao J; Yu H; Huang J
Medicine (Baltimore); 2021 May; 100(21):e25993. PubMed ID: 34032716
[TBL] [Abstract][Full Text] [Related]
16. JMJD3 expression is an independent prognosticator in patients with esophageal squamous cell carcinoma.
Li SH; Lu HI; Chen YH; Lo CM; Huang WT; Tien WY; Lan YC; Tsai HT; Chen CH
Surgery; 2019 May; 165(5):946-952. PubMed ID: 30678869
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
18. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.
Wang Y; Zhu L; Xia W; Wu L; Wang F
World J Surg Oncol; 2018 Nov; 16(1):216. PubMed ID: 30404621
[TBL] [Abstract][Full Text] [Related]
19. MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma.
Minami T; Yuasa N; Miyake H; Takeuchi E; Nagai H; Ito M; Kiriyama A; Miyata K
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29272372
[TBL] [Abstract][Full Text] [Related]
20. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
